Atlas Trials

Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus

Clinical trial NCT03288324 · COMPLETED

Trial details

NCT number
NCT03288324
Sponsor
Children's Hospital Medical Center, Cincinnati
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cutaneous LupusSystemic Lupus Erythematosus
Start date
2017-08-23
Primary completion
2022-11-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.